Immunohistochemical labeling for Dpc4 mirrors genetic status in pancreatic adenocarcinomas: A new marker of DPC4 inactivation

American Journal of Pathology

Volumn 156, Issue 1, 2000, Pages 37-43

  Wilentz, R E ^a   Su, G H ^a   Le Dai, J ^a   Sparks, A B ^a   Argani, P ^a   Sohn, T A ^a   Yeo, C J ^a   Kern, S E ^a   Hruban, R H ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GENETICS; GENE DELETION; GENE EXPRESSION; GENE MUTATION; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0033891752     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64703-7     Document Type: Article

References (40)

1. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1
2. Homozygous deletion map at 18q21.1 in pancreatic cancer
3. DPC4 gene in various tumor types
4. Tumor-suppressive pathways in pancreatic carcinoma
5. Tumor-suppressor genes in pancreatic cancer
6. DPC4 gene mutation in colitis associated neoplasia
7. Mutations of the DPC4/Smad4 gene in biliary tract carcinoma
8. Mutations of the DPC4/Smad4 gene in neuroendocrine pancreatic tumors
9. Evaluation of candidate tumor suppressor genes on chromosome 18 in colorectal cancers
10. Somatic alterations of the DPC4 gene in human colorectal cancers in vivo
11. Aaltonen LA: Mutations in the SMAD4/DPC4 gene in juvenile polyposis
12. A gene for familial juvenile polyposis maps to chromosome 18q21.1
13. Allelotype of pancreatic adenocarcinoma using xenograft enrichment
14. Nonparametric estimation from incomplete observations
15. +
16. DPC4/SMAD4 gene alterations in human cancer, and their functional implications
17. Human Smad3 and Smad4 are sequence-specific transcription activators
18. Direct binding of Smad3 and Smad4 to critical TGF β-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene
19. Dpc4 transcriptional activation, and dysfunction in cancer cells
20. The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGF-β-induced transcriptional activation
21. Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes
22. Dual role of the Smad4/DPC4 tumor suppressor in TGFβ-inducible transcriptional complexes
23. DPC4 (SMAD4) mediates transforming growth factor-β1 (TGF-β1) induced growth inhibition, and transcriptional response in breast tumour cells
24. MADR2 maps to 18q21, and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma
25. MADR2 is a substrate of the TGFβ receptor, and its phosphorylation is required for nuclear accumulation, and signaling
26. A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway
27. Transforming growth factor β signaling through Smad1 in human breast cancer cells
28. Characterization of functional domains within Smad4/DPC4
29. Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways
30. Induction of p21waf1 expression and growth inhibition by transforming growth factor β involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells
31. The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function
32. Targeted deletion of Smad4 shows it is required for transforming growth factor β and activin signaling in colorectal cancer cells
33. Receptor-associated Mad homologues synergize as effectors of the TGF-β response Nature
34. TGFβ responsiveness in DPC4/SMAD4-null cancer cells
35. TGF-β induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway
36. Involvement of mutations in the DPC4 promoter in endometrial carcinoma development
37. Genetic alterations during colorectal-tumor development
38. Microallelotyping defines the sequence and tempo of allelic losses at tumour suppressor gene loci during colorectal cancer progression
39. Genetic heterogeneity of the c-K-ras locus in colorectal adenomas but not in adenocarcinomas
40. Molecular genetic profiles of colitis-associated neoplasms